News for 'Medicines Health Regulatory Authority'

Want A Mediclaim Policy For Mental Illness?

Want A Mediclaim Policy For Mental Illness?

Rediff.com28 Mar 2023

'While many policies say that they will cover mental illnesses, the wordings of a few still have mental illness as a permanent exclusion.' 'After the new IRDAI circular, such exclusions should go away.'

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Repackaged drugs likely to be labelled 'new'

Repackaged drugs likely to be labelled 'new'

Rediff.com2 Jan 2014

Roadblocks ahead as these medicines could face new clinical tests, more scrutiny

1 in 7 Indian drugs revealed as substandard

1 in 7 Indian drugs revealed as substandard

Rediff.com16 Feb 2016

More lucrative routinely prescribed drugs are at higher risk of failing quality standards

Internet is creating the digital divide, says Amartya Sen

Internet is creating the digital divide, says Amartya Sen

Rediff.com7 Jan 2016

Free Basics offers a limited version of the Internet on mobile phones.

Drug regulator lets pharma firms fix own penalty

Drug regulator lets pharma firms fix own penalty

Rediff.com20 Jan 2014

Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.

How dangerous is plastic packaging?

How dangerous is plastic packaging?

Rediff.com7 Jun 2016

After recognising its adverse health effects, the govt has now dismissed its own lab reports to conclude that the evidence against plastic is insufficient.

After US, Germany bans export of Ranbaxy's Dewas plant drugs

After US, Germany bans export of Ranbaxy's Dewas plant drugs

Rediff.com3 Dec 2014

The company did not comply to the 'good manufacturing practice' norms.

Why you MUST NOT ignore teenage depression

Why you MUST NOT ignore teenage depression

Rediff.com13 Mar 2019

Only 29 per cent of the adolescents surveyed could identify depression as a medical condition, says Pankaj Gupta.

Pharma crusader takes India's drug regulators to court

Pharma crusader takes India's drug regulators to court

Rediff.com7 Mar 2016

Dinesh Thakur is famous for exposing Ranbaxy safety problems

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Vaccination for COVID-19 will be voluntary: Govt

Vaccination for COVID-19 will be voluntary: Govt

Rediff.com18 Dec 2020

The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.

Why is Novartis likely to lose Tiamulin drug licence?

Why is Novartis likely to lose Tiamulin drug licence?

Rediff.com19 Mar 2014

Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

Home healthcare could be one of India's best bets

Home healthcare could be one of India's best bets

Rediff.com22 May 2021

Home healthcare remains a niche segment in India even today. Nightingale provides services, starting from family physicians, short- and long-term nursing care, post-hospitalisation care and physiotherapy to stroke rehabilitation, respiratory care, bedside caregivers and attendants, intensive care at home, lab tests and speech therapy.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

India's drug inspectors hard-pressed to scrutinise factories

India's drug inspectors hard-pressed to scrutinise factories

Rediff.com7 Apr 2014

There are just 1,500 drug inspectors responsible for more than 10,000 factories in India

Can Modi dig India out of the COVID hole?

Can Modi dig India out of the COVID hole?

Rediff.com8 May 2020

'A balanced head plus heart approach would be a full opening up of the economy including manufacturing and internal travel in the country but excluding COVID-19 hotspots,' recommends Jaimini Bhagwati.

After Maggi, regulator now watches food supplements

After Maggi, regulator now watches food supplements

Rediff.com15 Jun 2015

The category is expected to cross Rs 38,400 crore by 2020.

FULL TEXT: President's address to Parliament

FULL TEXT: President's address to Parliament

Rediff.com29 Jan 2021

Here's the full text of President Ram Nath Kovind's customary address to the joining sitting of Parliament on the first day of the budget session.

Insurers see a change agent in new FDI rules

Insurers see a change agent in new FDI rules

Rediff.com20 Mar 2015

Inflow of more funds is likely to widen the reach of insurance and drive M&A activities in the sector where growth has stalled.

'Ayushman Bharat will be a big flop'

'Ayushman Bharat will be a big flop'

Rediff.com9 Jul 2018

'The biggest gainers under this scheme would be insurance companies.' 'If the government is going to route the payments through the insurance companies, these companies will be making nearly 30 per cent of the money.' 'For instance, if the government is paying Rs 100, then Rs 30 will go to these insurance companies.' 'Only Rs 70 will be available for expenditure that will be incurred by the hospitals.'

Full text: What Modi, Obama agreed on

Full text: What Modi, Obama agreed on

Rediff.com25 Jan 2015

This is the joint statement issued by the ministry of external affairs on the visit of US President Barack Obama to India.

« Prev  |